UW Tacoma News | August 4, 2022
UW Tacoma Assistant Professor Sunny Cheng's research focuses on mental health, particularly the impact of early intervention and screening. Dr. Cheng's research is funded in part by the Garvey Institute for Brain Health Solutions.
Department News | June 28, 2022
Through our Small Grants Program launched in 2020, and with support from the Garvey Institute for Brain Health Solutions, we allocated nearly $100,000 to a terrific set of diverse proposals from faculty, staff and trainees on a wide range of topics. Kathleen Pagulayan, PhD, Abigail Schindler, PhD, Rebecca Hendrickson, PhD, and Sean Gibbons, PhD, completed […]
The Scientist | June 13, 2022
Researchers are turning to the immune system for help in treating addiction and preventing overdose including Marco Pravetoni, PhD, who is developing monoclonal antibodies against fentanyl and fentanyl analogs. Note: you need to register (for free) in order to view this article
Pharmaceutical Technology | May 30, 2022
Even with academic collaborations, private players are lagging behind public institutions in finding new treatments for opioid addiction. Marco Pravetoni, PhD, is currently working on developing a potential vaccine aimed at oxycodone, which is in Phase I trials, and aims to get vaccines targeting other drugs like fentanyl or heroin into the clinic in the coming years.
Right as Rain | May 25, 2022
Mollie Forrester, MSW, LICSW, explains how to break up with a therapist if treatment goals are not being met. Written by Lori Mae Yvette Calibuso Acob, Brain Health Science Writing intern at the Garvey Institute for Brain Health Solutions.
Garvey Institute news | April 30, 2022
Our Innovation Grants Program launched in 2020 funded a project led by Kristen Lindgren, PhD, ABPP and Michele Bedard-Gilligan, PhD, called “Improving Washingtonians’ resilience and recovery from traumatic events with a Trauma-Informed Care ECHO Clinic”.
Garvey Institute news | April 30, 2022
Our Innovation Grants Program launched in 2020 funded a project led by Amy Starosta, PhD, Jeanne Hoffman, PhD, and Kari Stephens, PhD, called “Opioid prescription and use following traumatic brain injury”.
The Seattle Times | April 23, 2022
Scientists, doctors, advocacy workers, and other community members gathered to discuss the next frontier of treating substance-use disorders and addiction: psychedelics. The meeting was convened by the Center for Novel Therapeutics in Addiction Psychiatry led by Nathan Sackett, MD and was sponsored, in part, by the Garvey Institute for Brain Health Solutions.
Department news | April 21, 2022
A growing body of research suggests that the use of psychedelic compounds combined with behavioral interventions may provide powerful treatment options for a range of addictions including alcohol use disorder, opioid use disorder, tobacco use disorder and others.
ARDC News | March 17, 2022
Debby Tsuang, MD, MSc, and her team are researching the best remote health tools to assess mental health symptoms for African Americans and better include them in research. Written by Lori Mae Yvette Calibuso Acob, Brain Health Science Writing intern at the Garvey Institute for Brain Health Solutions.